Compare Amphastar Pharmaceuticals Inc (AMPH) vs Wynn Resorts, Limited (WYNN) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Amphastar Pharmaceuticals Inc vs Wynn Resorts, Limited — how do they compare? Amphastar Pharmaceuticals Inc trades at $20.39 (market cap $868.62M), while Wynn Resorts, Limited trades at $105.27 (market cap $10.79B). The key difference: Wynn Resorts, Limited is far larger — about 12.4× Amphastar Pharmaceuticals Inc's market cap, and Wynn Resorts, Limited pays a 0.95% dividend while Amphastar Pharmaceuticals Inc pays none. Which is the better fit depends on your goals.
| AMPH | WYNN | |
|---|---|---|
Market Cap | $868.62M | $10.79B |
Sector | Health | Consumer Cyclical |
52-Week High | $30.81 | $133.34 |
52-Week Low | $16.87 | $94.37 |
Enterprise Value | $1.27B | $21.03B |
Dividend Yield | — | 0.95% |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Amphastar Pharmaceuticals Inc
Amphastar is a specialty pharmaceutical company that develops and markets injectable, intranasal, and inhalation products. Its portfolio includes both complex generic drugs and proprietary delivery systems.
Read more on AMPH →About Wynn Resorts, Limited
Wynn Resorts operates luxury casinos and resorts. The company was founded in 2002 by Steve Wynn, the former CEO. The company operates four megaresorts: Wynn Macau and Encore in Macao and Wynn Las Vegas and Encore in Las Vegas. Cotai Palace opened in August 2016 in Macao, Encore Boston Harbor in Massachusetts opened June 2019. Additionally, we expect the company to begin construction on a new building next to its existing Macao Palace resort in 2023, which we forecast to open in 2026. The company also operates Wynn Interactive, a digital sports betting and iGaming platform. The company received 76% and 24% of its 2019 prepandemic EBITDA from Macao and Las Vegas, respectively.
Read more on WYNN →
